Aurentz Vincent Net Worth & Insider Trades

Aurentz Vincent - Chief Business Officer, Epirus Biopharmaceuticals, Inc

As of December 21, 2015

What is Aurentz Vincent's Net Worth?

The current estimated net worth of Epirus Biopharmaceuticals, Inc's Chief Business Officer, Aurentz Vincent, is estimated to be about $5.6M . Aurentz Vincent owns about 5,000 units of Epirus Biopharmaceuticals, Inc common stock. In the last month at Epirus Biopharmaceuticals, Inc, Aurentz Vincent has sold an estimated value of $0 worth.

What is Aurentz Vincent's Past Insider Trading?

Aurentz Vincent's largest purchase order was 2,800 units , worth over $10.78K on December 11, 2015. In total, Aurentz Vincent has made about 3 transactions over a month of their time at Epirus Biopharmaceuticals, Inc. Aurentz Vincent usually trades in December, with the busiest year in 2015. The most recent transaction was a purchase order of 2,200 units , worth over $7.55K on December 21, 2015.

Vincent Aurentz

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Aurentz Vincent's' Mailing Address?

  • Mailing address is C/o Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego CA 92121 CA

What are Epirus Biopharmaceuticals, Inc's Past Insider Trades?

Epirus Biopharmaceuticals, Inc's most recent insider trade came on December 22, 2015 by Robert Ticktin who bought 3,000 units worth $11.16K . In the last 12 months, insiders at Epirus Biopharmaceuticals, Inc have sold an estimated value of $1.51M and bought an estimated value of $4.35M worth of shares. Insider trading is most common in March, with the busiest year in 2015. The most active traders at the company are Amit Munshi, Chief Executive Officer,  Michael Wyand, President and COO,  and Robert Ticktin, General Counsel .

EPIRUS Biopharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...